Cost effectiveness of statins in coronary heart disease.
about
Primary prevention of cardiovascular disease: cost-effectiveness comparisonThose who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.Statin cost effectiveness in primary prevention: a systematic review of the recent cost-effectiveness literature in the United States.When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.Cost-effectiveness of high, moderate and low-dose statins in the prevention of vascular events in the Brazilian public health system.Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular preventionSex differences in the effectiveness of statins after myocardial infarction.Effectiveness calculation in economic analysis: the case of statins for cardiovascular disease prevention.Spiralling Medical Costs: Why Canada Needs NICE Medicine.Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature.Prevalence of dyslipidemia and its association with other coronary artery disease risk factors among urban population in Southeast of Iran: results of the Kerman coronary artery disease risk factors study (KERCADRS).Cost-effectiveness research in cancer therapy: a systematic review of literature trends, methods and the influence of fundingIncorporation of economic evidence in the Dutch guideline 'cardiovascular risk management'.Treatment of dyslipidemia and cardiovascular outcomes: the journey so far--is this the end for statins?
P2860
Q28217877-8A2D9EA7-8899-46F3-83AF-32839EBE39E1Q34025773-6D39F871-9BC6-4569-A3E8-82CC27B47F7FQ34350375-9F8B3317-3A88-4495-AB4B-ADA5A5D4FD2EQ34828582-9DE6C809-E6A7-4714-A9BB-A4EC6A618E77Q35292482-3C98A7D7-3A7D-480C-A5B6-6735465AEB7EQ35431592-5B07A93B-E95F-4436-AE02-EEAEE04E4A8FQ35607051-7FBAE0E8-A8EF-47A8-9A44-A81A842C6CABQ35681298-1B385F73-F7BF-4156-9606-35AD30D24F12Q37103310-9BA2E647-F953-4CF9-9BA3-C8B0209DDFE8Q37306497-28B6A662-9FE4-4EB2-814E-21C824A53D05Q37355814-F3195151-9C58-4B05-8252-A2160FE7C595Q37612154-130EE866-FDDF-4B88-B2A0-8DC7A8F37AF3Q37805717-9BCCEABA-53D7-4E39-9F8B-D428CBDCF44FQ38204182-0B8960D2-5299-4996-B03B-FF73E5CA110C
P2860
Cost effectiveness of statins in coronary heart disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cost effectiveness of statins in coronary heart disease.
@ast
Cost effectiveness of statins in coronary heart disease.
@en
type
label
Cost effectiveness of statins in coronary heart disease.
@ast
Cost effectiveness of statins in coronary heart disease.
@en
prefLabel
Cost effectiveness of statins in coronary heart disease.
@ast
Cost effectiveness of statins in coronary heart disease.
@en
P2093
P2860
P356
P1476
Cost effectiveness of statins in coronary heart disease.
@en
P2093
Anna Peeters
Caspar W N Looman
Luc Bonneux
P2860
P304
P356
10.1136/JECH.2005.034900
P577
2005-11-01T00:00:00Z